10-Q: Forward Industries Reports Q3 2024 Results, Navigates Strategic Shift and Financial Challenges
Quarterly Report
Forward Industries reports a net loss for Q3 2024, impacted by the discontinuation of its retail segment and declining revenues in both OEM distribution and design segments.
Summary
- Forward Industries reported a net loss of $1.307 million for the nine months ended June 30, 2024, and a loss from continuing operations of $1.304 million.
- The company experienced a decrease in net revenues of $5.33 million, or 18.9%, compared to the same period last year, with declines in both the OEM distribution and design segments.
- Gross profit decreased by $1.225 million, or 20.1%, due to lower utilization rates in the design segment and a change in the mix of OEM distribution revenue.
- The company discontinued its retail distribution segment in July 2023, which is now reported as discontinued operations.
- A 1-for-10 reverse stock split was implemented on June 18, 2024.
- Forward China agreed to limit the amount of outstanding payables it would seek to collect from the Company to $500,000 in any 12-month period.
- The company entered into an agreement with Forward China to convert $1.7 million of debt into preferred stock, effective July 5, 2024.
- The company believes its existing cash balance and working capital will be sufficient to meet its liquidity needs through at least August 31, 2025.
Sentiment
Score: 3
Explanation: The document indicates a negative sentiment due to significant losses, declining revenues, and a working capital deficit. While the company has taken steps to improve liquidity and regain Nasdaq compliance, the overall financial performance is concerning.
Positives
- The company has taken steps to improve liquidity by limiting payables to Forward China and converting debt to preferred stock.
- The company expects improved performance in future periods by discontinuing the retail segment.
- The company has the ability to implement cost-cutting measures if necessary.
- The company regained compliance with Nasdaq listing standards.
- The company reduced its sourcing fee with Forward China.
Negatives
- The company experienced a significant net loss and a decrease in revenues.
- The design segment experienced a significant decline in revenue and operating income.
- The OEM distribution segment saw a decrease in revenue from diabetic products.
- The company has a working capital deficit of $1.576 million.
- The company's gross margin decreased significantly.
- The company is reliant on Forward China for sourcing and financing.
Risks
- The company is dependent on a few large customers, which can cause revenue variability.
- The company faces pricing pressures and competition.
- The company's design division's customers may not be able to pay for services.
- The company is subject to supply chain issues and potential disruptions.
- The company may not be able to maintain compliance with Nasdaq listing standards in the future.
- The company is reliant on Forward China for sourcing and financing, and there is no guarantee that Forward China will extend the FC Note or payment terms.
- The company may not be able to raise additional capital on acceptable terms.
Future Outlook
The company expects improved performance in future periods by discontinuing the retail segment and believes its existing cash balance and working capital will be sufficient to meet its liquidity needs through at least August 31, 2025. The company also anticipates that the loss of a major diabetic customer will continue to cause a significant decline in OEM distribution segment revenues in future periods.
Management Comments
- Management continues to monitor the various components of general and administrative expenses and how these costs are affected by inflationary and other factors.
- We intend to adjust these costs as needed based on the overall needs of the business.
- Management believes that revenues from diabetic customers will decline in future periods.
- We will continue to focus on our sales and sales support teams in our continued efforts to expand and diversify our other products customer base.
Industry Context
The company's performance is affected by the broader trends in the medical and technology industries, including demand for diabetic testing products and portable electronic devices. The company's strategic shift away from retail distribution reflects a broader trend of companies focusing on core competencies and higher-margin businesses.
Comparison to Industry Standards
- Forward Industries' performance is below industry standards for profitability, as evidenced by the net loss and declining gross margins.
- Comparable companies in the medical device accessories and product design sectors, such as Integer Holdings Corporation and Flex Ltd., typically report higher gross margins and positive net income.
- Forward's reliance on a single sourcing agent and related party transactions is not typical of larger, more diversified companies in the industry.
- The company's strategic shift away from retail is similar to actions taken by other companies to streamline operations and focus on core competencies, such as the divestiture of non-core assets by companies like Jabil Inc.
Related Party Transactions
- The company has a Buying Agency and Supply Agreement with Forward China, a related party owned by the company's CEO.
- The company purchases products from Forward China at cost plus a service fee.
- The company has a promissory note payable to Forward China.
- The company entered into an agreement with Forward China to convert $1.7 million of debt into preferred stock.
- The company had revenue from a customer whose principal owner is an immediate family member of a significant shareholder and managing director of Forward China.
- The company had revenue from a customer who employs an immediate family member of a former member of our Audit, Governance and Compensation committees of our Board of Directors.
Stakeholder Impact
- Shareholders are negatively impacted by the net loss and declining share price.
- Employees may be affected by potential cost-cutting measures, including reductions in labor force and/or salary reductions.
- Customers may be affected by changes in product offerings and pricing.
- Suppliers may be affected by changes in purchasing volumes and payment terms.
- Creditors may be concerned about the company's liquidity and ability to repay debt.
Next Steps
- The company will continue to focus on expanding and diversifying its customer base in the OEM distribution segment.
- The company will continue to monitor and adjust general and administrative expenses.
- The company will continue to manage its liquidity and working capital.
- The company will seek to repay the promissory note to Forward China by December 31, 2024.
Key Dates
| Date | Description |
|---|---|
| 2018-01-18 | Promissory note issued to Forward China to fund the acquisition of IPS. |
| 2023-07 | Company decided to cease operations of its retail distribution segment. |
| 2023-10-01 | Options granted to non-employee directors. |
| 2023-10-30 | Date of outstanding payables to Forward China covered by the agreement to limit collections. |
| 2023-11 | Agreement with Forward China to limit outstanding payables. |
| 2024-06-18 | 1-for-10 reverse stock split became effective. |
| 2024-07-05 | Conversion of debt to preferred stock with Forward China became effective. |
| 2024-07-31 | Number of shares of the registrants common stock outstanding. |
| 2025-08-31 | Company believes its existing cash balance and working capital will be sufficient to meet its liquidity needs through at least this date. |
Keywords
Forward Industries, OEM distribution, design segment, financial results, reverse stock split, Nasdaq compliance, Forward China, liquidity, discontinued operations, preferred stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.